In further signs of positive momentum, UK listed cannabis stocks made an unexpected comeback this week, following months of unrelenting
CELADON Pharmaceuticals successfully listed on the Alternative Investments Market (AIM) this week, making it the first British company to join
FEBRUARY 2022 marked the one-year anniversary of MGC Pharmaceuticals IPO on the London Stock Exchange, which saw cannabis stocks traded on the platform for the first time in its 320-year history.Â
On the 1-year anniversary of the first cannabis company to list on the London Stock Exchange, we examine the reaction to a number of significant announcements from some of the UK’s biggest cannabis players, making for an eventful week in the markets.Â
THIS has been a transformative year for the European cannabis industry, with growing liberalisation across the continent opening the floodgates
CELLULAR Goods has announced that health and beauty industry veteran Anna Chokina has replaced Alexis Abraham as its new CEO
Oxford Cannabinoid Technologies (OCT) has seen its second senior departure in under a month as it begins to recover from
MGC Pharmaceuticals told shareholders attending its Annual General Meeting (AGM) that it is on track to deliver ‘far and away
Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the
THE Chairman of a recently-listed UK pharmaceutically-focused cannabis company has stood down after a breach of market rules. Neil Mahapatra
We won’t spam you
© 2023 Prohibition Holdings Ltd. All Rights Reserved.
